1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Defence Therapeutics Inc.
  6. News
  7. Press Releases
    DTC   CA24463V1013

DEFENCE THERAPEUTICS INC.

(DTC)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société DEFENCE THERAPEUTICS INC.
05/18Defence?s novel accuvac-pte7 vaccine shows complete protection from cervical cancer
EQ
04/07Defence therapeutics announces issuance of a u.s. patent covering its pioneering vaccin..
EQ
03/22DEFENCE THERAPEUTICS : An anti-cancer solutions platform company advancing its versatile a..
EQ
02/28DEFENCE THERAPEUTICS INC. : Defence releases peer-reviewed publication of its preclinical ..
EQ
02/16DEFENCE THERAPEUTICS INC. : Defence retains cato sms to advise on its phase i clinical tri..
EQ
01/26DEFENCE THERAPEUTICS INC. : Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) acti..
EQ
01/10Defence therapeutics achieves a major milestone and begins ind-enabling testing of its ..
EQ
2021Defence therapeutics accumtm boosts by 9-fold the delivery effectiveness of the crispr/..
EQ
2021Defence therapeutics vaccines and program development
EQ
2021Defence therapeutics cancer vaccine accuvac-d001 manufacturing targets melanoma and bre..
EQ
2021Defence therapeutics appoints dr. riam shammaa to its board of directors
EQ
2021VACCINE RESULTS : Defence therapeutics reports successful completion of its covid-19 vacci..
EQ
2021Defence Therapeutics Scores Again With New Planned Phase 1 Trial Evaluating Its DC Canc..
AQ
2021DEFENCE THERAPEUTICS INC. : Defence therapeutics accumtm variants in vitro study increases..
EQ
2021DEFENCE THERAPEUTICS ACCUM(TM) TECHN : Dtcff)
AQ
2021DEFENCE THERAPEUTICS INC. : Defence therapeutics prepares for phase i trial to test its dc..
EQ
2021DEFENCE THERAPEUTICS DRAWS INTEREST : Dtcff)
AQ
2021DEFENCE THERAPEUTICS : To finalize its objectives to initiate a phase i trial against brea..
EQ
2021DEFENCE THERAPEUTICS IS ADVANCING NE : Dtcff)
AQ
2021DEFENCE THERAPEUTICS : Successfully engineered and tested a novel intranasal covid-19 vacc..
EQ
2021DEFENCE THERAPEUTICS : Success in testing its covid 19 accuvac pt001 vaccine in a non rode..
AQ
2021DEFENCE THERAPEUTICS : Success in testing it's covid-19 accuvac-pt001 vaccine in a non-rod..
EQ
2021DEFENCE THERAPEUTICS : Development program to engineer a new hpv vaccine initiated
EQ
2021DEFENCE THERAPEUTICS : Files acid-based hydrogels usa provisional patent application
EQ
2021Defence therapeutics selects the best 8 accumtm variants to optimize its adc therapeuti..
AQ
2021DEFENCE THERAPEUTICS : Selects the best 8 accum(tm) variants to optimize its adc therapeut..
EQ
2021DEFENCE THERAPEUTICS INC. : Defence therapeutics receives dtc eligibility
EQ
2021DEFENCE THERAPEUTICS : Signs an agreement with biopharma excellence a pharmalex gmbh compa..
EQ
2021DEFENCE THERAPEUTICS : The antibody response induced by defence therapeutics accuvac? pt00..
AQ
2021DEFENCE THERAPEUTICS : The antibody response induced by defence therapeutics accuvac-pt001..
EQ
2021DEFENCE THERAPEUTICS : Signs a collaboration agreement with the curie institute for testin..
EQ
2021DEFENCE THERAPEUTICS : Accutox exhibits potent anti cancer properties
AQ
2021DEFENCE THERAPEUTICS INC. : Defence therapeutics accutox exhibits potent anti-cancer prope..
EQ
2021DEFENCE THERAPEUTICS : Retains the hus comprehensive cancer center to optimize its accum-t..
EQ
2021DEFENCE THERAPEUTICS : Advances in pre-clinical testing of its infectious disease vaccine ..
EQ
2021DEFENCE THERAPEUTICS : Accuvac-d001 cancer vaccine generates effective long-lasting anti-t..
EQ
2021DEFENCE THERAPEUTICS, STRONG THERAPE :  ADC's, CANCER AND COVID VACCINES
EQ
Upcoming event on DEFENCE THERAPEUTICS INC.